{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:34:43Z","timestamp":1763559283819,"version":"3.45.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["SAC150061"],"award-info":[{"award-number":["SAC150061"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF-22-190"],"award-info":[{"award-number":["BCRF-22-190"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10552-025-02078-0","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:43:49Z","timestamp":1762033429000},"page":"2039-2050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of care and treatment delays among patients with early-stage breast cancer: long term impact of the COVID-19 (C19) pandemic"],"prefix":"10.1007","volume":"36","author":[{"given":"Inimfon","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiudong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Chavez-MacGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267584","volume":"17","author":"Y Kim","year":"2022","unstructured":"Kim Y, Zhu L, Zhu H et al (2022) Characterizing cancer and COVID-19 outcomes using electronic health records. PLoS ONE 17:e0267584","journal-title":"PLoS ONE"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.2217\/fon-2021-0121","volume":"17","author":"M Aboueshia","year":"2021","unstructured":"Aboueshia M, Hussein MH, Attia AS et al (2021) Cancer and COVID-19: analysis of patient outcomes. Future Oncol 17:3499\u20133510","journal-title":"Future Oncol"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","volume":"7","author":"Q Wang","year":"2021","unstructured":"Wang Q, Berger NA, Xu R (2021) Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol 7:220\u2013227","journal-title":"JAMA Oncol"},{"key":"2078_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000947","volume":"5","author":"E De Azambuja","year":"2020","unstructured":"De Azambuja E, Brand\u00e3o M, Wildiers H et al (2020) Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. ESMO Open 5:e000947","journal-title":"ESMO Open"},{"key":"2078_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21:335\u2013337","journal-title":"Lancet Oncol"},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-024-07301-1","volume":"206","author":"M Sullivan","year":"2024","unstructured":"Sullivan M, Lei X, Giordano SH, Chavez-MacGregor M (2024) Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis. Breast Cancer Res Treat 206:307\u2013316","journal-title":"Breast Cancer Res Treat"},{"key":"2078_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/GO.20.00639","volume":"7","author":"R Riera","year":"2021","unstructured":"Riera R, Bagattini \u00c2M, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A (2021) Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol 7:311\u2013323","journal-title":"JCO Glob Oncol"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.21873\/invivo.11957","volume":"34","author":"G Vanni","year":"2020","unstructured":"Vanni G, Materazzo M, Pellicciaro M et al (2020) Breast cancer and COVID-19: the effect of fear on patients\u2019 decision-making process. In Vivo 34:1651\u20131659","journal-title":"In Vivo"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.breast.2020.05.006","volume":"52","author":"ML Gasparri","year":"2020","unstructured":"Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110\u2013115","journal-title":"Breast"},{"key":"2078_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1478951520000516","volume":"18","author":"S Shinan-Altman","year":"2020","unstructured":"Shinan-Altman S, Levkovich I, Tavori G (2020) Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care 18:385\u2013391","journal-title":"Palliat Support Care"},{"key":"2078_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-020-05828-7","volume":"184","author":"EL Papautsky","year":"2020","unstructured":"Papautsky EL, Hamlish T (2020) Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat 184:249\u2013254","journal-title":"Breast Cancer Res Treat"},{"key":"2078_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","volume":"2","author":"M Chavez-MacGregor","year":"2016","unstructured":"Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH (2016) Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2:322\u2013329","journal-title":"JAMA Oncol"},{"key":"2078_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1634\/theoncologist.2019-0744","volume":"25","author":"D de Melo Gagliato","year":"2020","unstructured":"de Melo Gagliato D, Lei X, Giordano SH et al (2020) Impact of delayed neoadjuvant systemic chemotherapy on overall survival among patients with breast cancer. Oncologist 25:749\u2013757","journal-title":"Oncologist"},{"key":"2078_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.2013.49.7693","volume":"32","author":"M Gagliato Dde","year":"2014","unstructured":"Gagliato Dde M, Gonzalez-Angulo AM, Lei X et al (2014) Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 32:735\u2013744","journal-title":"J Clin Oncol"},{"key":"2078_CR15","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1002\/cam4.3363","volume":"9","author":"D Smith-Graziani","year":"2020","unstructured":"Smith-Graziani D, Lei X, Giordano SH, Zhao H, Karuturi M, Chavez-MacGregor M (2020) Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med. 9:6961\u201371","journal-title":"Cancer Med."},{"key":"2078_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2:330\u2013339","journal-title":"JAMA Oncol"},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-021-06153-3","volume":"188","author":"KU Park","year":"2021","unstructured":"Park KU, Gregory M, Bazan J et al (2021) Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic. Breast Cancer Res Treat 188:249\u2013258","journal-title":"Breast Cancer Res Treat"},{"key":"2078_CR18","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1245\/s10434-021-11088-6","volume":"29","author":"JE Tonneson","year":"2022","unstructured":"Tonneson JE, Hoskin TL, Day CN, Durgan DM, Dilaveri CA, Boughey JC (2022) Impact of the COVID-19 pandemic on breast cancer stage at diagnosis, presentation, and patient management. Ann Surg Oncol 29:2231\u20132239","journal-title":"Ann Surg Oncol"},{"key":"2078_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2023.05.010","author":"JL Sturz","year":"2023","unstructured":"Sturz JL, Boughey JC (2023) Lasting impacts of the COVID-19 pandemic on breast cancer diagnosis and treatment in the United States. Surg Oncol Clin N Am. https:\/\/doi.org\/10.1016\/j.soc.2023.05.010","journal-title":"Surg Oncol Clin N Am"},{"key":"2078_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10549-022-06634-z","volume":"194","author":"JL Caswell-Jin","year":"2022","unstructured":"Caswell-Jin JL, Shafaee MN, Xiao L et al (2022) Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Res Treat 194:475\u2013482","journal-title":"Breast Cancer Res Treat"},{"key":"2078_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K et al (2017) Using the National Cancer Database for outcomes research: a review. JAMA Oncol 3:1722\u20131728","journal-title":"JAMA Oncol"},{"key":"2078_CR22","doi-asserted-by":"publisher","first-page":"e35525","DOI":"10.1002\/cncr.35525","volume":"131","author":"JK Plichta","year":"2025","unstructured":"Plichta JK, Thomas SM, Chanenchuk TC et al (2025) Comparison of incident breast cancer cases in the largest national US tumor registries. Cancer 131:e35525","journal-title":"Cancer"},{"key":"2078_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01073-7","volume":"14","author":"AH Eijkelboom","year":"2021","unstructured":"Eijkelboom AH, de Munck L, Vrancken Peeters M-JT et al (2021) Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol 14:1\u201312","journal-title":"J Hematol Oncol"},{"key":"2078_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/09691413221101807","volume":"29","author":"JS Ng","year":"2022","unstructured":"Ng JS, Hamilton DG (2022) Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: a rapid review and meta-analysis. J Med Screen 29:209\u2013218","journal-title":"J Med Screen"},{"key":"2078_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","volume":"67","author":"T Li","year":"2023","unstructured":"Li T, Nickel B, Ngo P et al (2023) A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. Breast 67:78\u201388","journal-title":"Breast"},{"key":"2078_CR26","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1002\/cam4.5439","volume":"12","author":"J Berrian","year":"2023","unstructured":"Berrian J, Liu Y, Ezenwajiaku N et al (2023) Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race. Cancer Med 12:7381\u20137388","journal-title":"Cancer Med"},{"key":"2078_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1245\/s10434-021-11223-3","volume":"29","author":"N Tamirisa","year":"2022","unstructured":"Tamirisa N, Hunt KK (2022) Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. Ann Surg Oncol 29:1489\u20131492","journal-title":"Ann Surg Oncol"},{"key":"2078_CR28","doi-asserted-by":"publisher","first-page":"7562","DOI":"10.1245\/s10434-024-15787-8","volume":"31","author":"R Khorfan","year":"2024","unstructured":"Khorfan R, Vora HP, Namm JP, Solomon NL, Lum SS (2024) Expanded indications for neoadjuvant endocrine therapy in early-stage breast cancer during the COVID-19 pandemic. Ann Surg Oncol 31:7562\u20137568","journal-title":"Ann Surg Oncol"},{"key":"2078_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-020-05644-z","volume":"181","author":"JR Dietz","year":"2020","unstructured":"Dietz JR, Moran MS, Isakoff SJ et al (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181:487\u2013497","journal-title":"Breast Cancer Res Treat"},{"key":"2078_CR30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1200\/OP.20.00807","volume":"17","author":"K Hawrot","year":"2021","unstructured":"Hawrot K, Shulman LN, Bleiweiss IJ et al (2021) Time to treatment initiation for breast cancer during the 2020 COVID-19 pandemic. JCO Oncol Pract 17:534\u2013540","journal-title":"JCO Oncol Pract"},{"key":"2078_CR31","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1200\/OP.20.01062","volume":"17","author":"T Satish","year":"2021","unstructured":"Satish T, Raghunathan R, Prigoff JG et al (2021) Care delivery impact of the COVID-19 pandemic on breast cancer care. JCO Oncol Pract 17:e1215\u2013e1224","journal-title":"JCO Oncol Pract"},{"key":"2078_CR32","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1245\/s10434-022-12139-2","volume":"29","author":"KA Kapp","year":"2022","unstructured":"Kapp KA, Cheng A-L, Bruton CM, Ahmadiyeh N (2022) Impact of COVID-19 restrictions on stage of breast cancer at presentation and time to treatment at an urban safety-net hospital. Ann Surg Oncol 29:6189\u20136196","journal-title":"Ann Surg Oncol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02078-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:31:06Z","timestamp":1763559066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02078-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02078-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the procedures were followed according to the regulations established by the Clinical Research and Ethics Committee and to the Helsinki Declaration of the World Medical Association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study uses de-identified data from the NCDB. No individual patient consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}